|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 15 studies with search of: | Open Studies | "Measles" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
|
||||
| 2 | Recruiting |
Additional Measles Vaccine at 4 Months of Age
|
||||
| 3 | Unknown † |
Ontogeny of Measles Immunity in Infants
|
||||
| 4 | Not yet recruiting |
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children
|
||||
| 5 | Recruiting |
Making Decisions About the MMR Vaccine
|
||||
| 6 | Unknown † |
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
|
||||
| 7 | Recruiting |
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
|
||||
| 8 | Recruiting |
Study of QUADRACEL® Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
|
||||
| 9 | Recruiting |
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
|
||||
| 10 | Recruiting |
The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
|
||||
| 11 | Recruiting |
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
|
||||
| 12 | Recruiting |
IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis
|
||||
| 13 | Recruiting |
Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
|
||||
| 14 | Recruiting |
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
|
||||
| 15 | Recruiting |
Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine
|